We aimed to evaluate the role of extracorporeal shockwave therapy (ESWT) in improving osteonecrosis of the femoral head (ONFH).
Methods
We searched studies focusing on the role of ESWT in ONFH using PubMed, Embase, the Cochrane Library, WanFang, VIP, and CNKI databases updated up to July 28, 2017, without language restriction. Standardized mean difference (SMD) values and 95% confidence intervals (95% CIs) were pooled to compare the pain score and Harris hip score for ESWT treatment and other treatment strategies.
Results
Four articles, including 230 ONFH patients, were eligible for the meta-analysis. No significant differences were found in the pain score (SMD = − 1.0104; 95% CI − 2.3279–0.3071) and Harris hip score (SMD = 0.3717; 95% CI − 0.3125–1.0559) between the two groups before treatment. After treatment, significant differences were found between the experimental and control groups in the pain score (SMD = − 2.1148; 95% CI − 3.2332–0.9965) and Harris hip score (SMD = 2.1377; 95% CI 1.2875–2.9880). There were no significant differences in pain score before and after treatment between the two groups (SMD = − 0.7353; 95% CI − 2.1272–0.6566), but significant differences were found in the Harris hip score (SMD = 1.2969; 95% CI 0.7171–1.8767).
Conclusion
For patients at an early stage, ESWT may be safe and effective for relief of pain and improvement of motor function.
Hinweise
Yangquan Hao and Hao Guo contributed equally to this work.
Abkürzungen
CI
Confidence interval
ESWT
Extracorporeal shockwave therapy
ONFH
Osteonecrosis of the femoral head
SMD
Standardized mean difference
Background
Osteonecrosis of the femoral head (ONFH) is a pathological process that follows ischemic insult [1]. High morbidity occurs in both young and old worldwide [2]. In China, 8.12 million patients have been diagnosed with ONFH as of 2017 [3, 4], and the average annual number of new cases in Korea was 14,103 [5]. The occurrence of osteonecrosis is associated with various risk factors including trauma, hip surgery, corticosteroid use, alcoholism, and coagulopathy [6]. The treatment of ONFH remains a challenge, and a standardized and improved treatment strategy for ONFH is urgently needed.
“Joint-preserving” treatments, including both surgical (such as core decompression, trochanteric rotational osteotomy, and vascularized bone grafts) and conservative approaches [extracorporeal shock wave therapy (ESWT) and pulsed electromagnetic field] have been developed to prevent progression of ONFH [7, 8]. ESWT is used in physical therapy, orthopedics, urology, and cardiology, and a previous study demonstrated that the technology can successfully treat ONFH [9]. However, the efficacy of ESWT compared with other treatments remains unclear [10, 11]. For example, no significant difference in efficacy was found between ESWT and core decompression in a study by Wang et al. [10]. A study by Chen and colleagues demonstrated better outcomes with ESWT than with physical therapy [12]. Although the effect of ESWT in the treatment of ONFH has been investigated by previous researchers, there is no consistent conclusion about its efficacy when compared with other treatments.
Anzeige
This meta-analysis was performed to evaluate the role of ESWT in improving ONFH. Standardized mean difference (SMD) values and 95% confidence intervals (95% CIs) were pooled to compare the pain score and Harris hip score for ESWT treatment and other treatment strategies.
Methods
Study selection
Studies were selected using PubMed (http://www.ncbi.nlm.nih.gov/pubmed), Embase (http://www.embase.com), the Cochrane Library (http://www.cochranelibrary.com), WanFang, VIP, and CNKI databases updated to July 28, 2017, without language restriction. A combination of Medical Subject Headings (MeSH) terms and free-text keywords were used for study selection: (“ESWT” OR “Extracorporeal shock wave”) AND (“osteonecrosis” OR “Osteonecrosis” OR “femoral head necrosis” OR “ONFH” OR “Osteonecrosis of the Femoral Head” OR “avascular necrosis of femoral head” OR “necrosis of the femoral head” OR “avascular necrosis of bone” OR “Kienbock disease” OR “Aseptic necrosis of bone”).
Selection criteria
Literature focusing on the efficacy of ESWT in patients with femoral head necrosis were included in the meta-analysis. Studies were included in the meta-analysis if they met the following criteria: (1) published Chinese or English language literature focusing on the efficacy of ESWT in patients with ONFH, in which the experimental group was treated with ESWT and the control group received a different treatment strategy; (2) reported outcomes included the pain score and Harris hip score at baseline and corresponding scores after a period of treatment; and (3) research designed as an interventional study.
Exclusion criteria were as follows: (1) incomplete data or data that could not be used for statistical analysis and (2) reviews, letters, and comments. In addition, if studies duplicated published literature or data for the same population, only the latest research with the most comprehensive information was included.
Anzeige
Data extraction and quality evaluation
The authors independently extracted the following data from the included literature: the first author’s name, year of publication, study period, stage of ONFH (according to Association Research Circulation Osseous), type of study, follow-up duration, baseline characteristics of enrolled patients (e.g., sex ratio, age composition), baseline pain and Harris hip scores, and corresponding scores after treatment, sample sizes, and general demographic data.
The quality of randomized controlled trials was evaluated using Cochrane Collaboration recommendations [13]. Disagreements were resolved by discussion or by consultation with a third reviewer.
Statistical analysis
Meta-analysis was performed using R 3.12 software (R Foundation for Statistical Computing, “meta” package, Beijing, China). The SMD values and 95% CIs were pooled to compare the pain score and Harris hip score for ESWT treatment and other treatment strategies. For P < 0.05 or I2 > 50%, the random effects model was used to calculate the combined effect value. Otherwise, the fixed effects model was chosen to combine data [14]. Publication bias was assessed using Egger’s method. Finally, sensitivity analysis was performed by omitting one study at a time to determine the effect on the overall SMD value.
Results
The general characteristics of included studies
The flow chart used for study selection is shown in Fig. 1. Of 482 articles initially reviewed, 48 were from PubMed, 91 from Embase, 4 from the Cochrane Library, 61 from WanFang, 46 from VIP, and 232 from CNKI. After excluding duplicated literature, 295 articles were left. Then, the title and abstract were reviewed, and 221 articles obviously inconsistent with the inclusion criteria excluded. Subsequently, a total of 74 articles were fully reviewed, and 52 articles were excluded including 9 letters, 14 reviews, 10 case series/reports, and 19 animal studies. Moreover, another 18 articles including 9 articles without relevant data, 6 descriptive studies, and 3 reduplicative studies were excluded. Finally, 4 articles were included in the meta-analysis [10, 12, 14, 15].
Fig. 1
Flow chart of study selection
×
A total of 230 patients (185 men and 45 women, a significant difference) with ONFH were enrolled in this study, including 120 in the experimental group and 110 in the control group. The general characteristics of the selected literature are shown in Table 1. The publication year ranged from 2008 to 2015. Patients with ONFH were mainly in stages I–III. Only one randomized controlled study was included. No significant difference in sex or age distribution was found in individual studies. Follow-up time in three studies was more than 1 year. Figure 2 shows that the quality of the included literature was relatively poor.
Table 1
The baseline characteristics of included studies
Study
Year
Study year
ONFH stage
Study style
Group
Number/hips
Gender (M/F)
Age (year)
Duration (month)
Wang CJ
2012
2001–2001
Stages I, II, early III
Non-RCT
ESWT
23/29
20/3
39.8 ± 12.1
25.2 ± 3.7
Surgical group
25/28
22/3
39.9 ± 9.3
25.8 ± 4.6
Chen JM
2009
1999.7–2006.1
Stages I–III
Non-RCT
ESWT
17/17
14/3
42.9 ± 9.3
11.3 ± 3.4
Stages I–IV
THA
17/17
14/3
42.9 ± 9.3
14.7 ± 0.93
Zhang HJ
2015
2009.1–2012.12
Stages I–II
RCT
BMSC+ESWT
20/29
15/5
36.1 ± 6.2
24
BMSC
20/27
14/6
35.5 ± 5.7
24
Zhai L
2008
1998.1–2007.6
Stages I–III
Non-RCT
CD + ESWT
50/50
41/9
20.9(18–25)
6.4(3–18)
CD
58/58
45/13
20.5(18–25)
7.3(3–20)
ESWT extracorporeal shock wave treatment, THA total hip arthroplasty, CD core decompression, M/F males/females, RCT randomized controlled trail, ONFH osteonecrosis of the femoral head, THA total hip, BMSC bone marrow stem cells
Fig. 2
Quality assessment of the meta-analysis. a Risk of bias. b risk of bias summary
×
Meta-analysis of pain score and Harris hip score
The pain and Harris hip scores before and after treatment in the experimental and control groups were analyzed. The main results are shown in Table 2 and Fig. 3. No significant differences were found between the two groups in the baseline pain score (SMD = − 1.0104;95% CI − 2.3279–0.3071) and baseline Harris hip score (SMD = 0.3717; 95% CI − 0.3125–1.0559). After a period of treatment, significant differences were found between the experimental and control groups in the pain score (SMD = − 2.1148; 95% CI − 3.2332–0.9965) and Harris hip score (SMD = 2.1377; 95% CI 1.2875–2.9880). No significant differences in pain score were found before and after treatment (SMD = − 0.7353; 95% CI − 2.1272–0.6566), but significant differences were found in the Harris hip score (SMD = 1.2969; 95% CI 0.7171–1.8767).
Table 2
Meta-analysis results for pain score and Harris hip score
Variable
Group
Sample size
Test of association
Model
Test of heterogeneitya, b
Egger’s testc
K
ESWT
Control
SMD (95% CI)
Z
P
Q
P
I2 (%)
t
P
Pain score
Base
2
46
45
−1.0104 [− 2.3279; 0.3071]
1.5032
0.1328
Random
6.61
0.0058
86.9
–
–
Post
2
46
45
− 2.1148 [− 3.2332; − 0.9965]
3.7063
0.0002
Random
4.42
0.0035
77.4
–
–
Change
2
46
46
− 0.7353 [− 2.1272; 0.6566]
1.0354
0.3005
Random
9.81
0.0017
89.8
–
–
Harris hip score
Base
4
125
130
0.3717 [− 0.3125; 1.0559]
1.0647
0.287
Random
34.06
< 0.001
85.3
1.9243
0.1267
Post
4
125
130
2.1377 [1.2875; 2.9880]
4.9281
< 0.001
Random
35.77
< 0.001
86.0
3.5824
0.0231
Change
4
125
125
1.2969 [0.7171; 1.8767]
4.3839
< 0.001
Random
20.72
0.001
75.9
0.9755
0.3846
OR odds ratio, CI confidence interval, K number of studies combined
aRandom-effects model was used when the P for heterogeneity test < 0.05; otherwise, the fixed-effect model was used
bP < 0.05 is considered statistically significant for Q statistics
cEgger’s test to evaluate publication bias, P < 0.05 is considered statistically significant
Fig. 3
Meta-analysis of pain score and Harris hip score. a Pain score. b Harris hip score
×
Publication bias
Significant bias was found among individual studies in the comparison of Harris hip scores (t = 3.5824, P = 0.0231), but no publication bias was found in the change before and after treatment (t = 0.9755, P = 0.3846) in the baseline pain score and Harris hip score (t = 1.9243, P = 0.1267).
Sensitivity analysis
Sensitivity analysis of pain scores demonstrated that the results were unstable, but sensitivity analysis of Harris hip scores demonstrated that the results were stable.
Anzeige
Discussion
In the present study, we evaluated the role of ESWT in improving ONFH. A total of 230 patients with ONFH were included in the study. No significant difference was found between the two groups in the pain score and Harris hip score before treatment. After treatment, significant differences were found between the experimental and control groups in the pain score and Harris hip score. No significant differences in pain score were found before and after treatment, but significant differences were found in the Harris hip score.
Physical therapy can improve bone oxygenation, reduce edema, reduce bone pressure, improve bone circulation, prevent ischemia, restore blood supply in hypoxic tissue, and promote necrotic bone repair [16]. Wang et al. demonstrated greater improvement with ESWT compared with core decompression and nonvascularized fibular grafting in patients with early-stage ONFH [17]. A previous study demonstrated that ESWT could increase the expression of angiogenic factors, reduce vessel wall stenosis, and improve limb perfusion [18]. The effect of ESWT might be related to stress-induced piezoelectricity, cavitation and osteogenesis, and metabolic activation. These effects promote healing of femoral head necrosis by inducing improved blood circulation, mitigating a hypercoagulable state, and enhancing osteoblast and blood vessel activity [18, 19]. Similar to previous reports, the present study suggested that ESWT might be a safe and effective method to improve motor function and relieve pain, especially at an early stage of ONFH. Significant heterogeneity was observed in the study. Heterogeneity might be introduced by different combined treatment strategies. For example, patients in experimental groups underwent ESWT in two studies [12], while patients in experimental groups in two other studies underwent combined treatment [15, 20]. Although the age difference between groups in individual studies was not significant, the age in the four studies ranged from 20.9 to 40.9 years. Bone density, structure, and strength are correlated with age [21, 22]. Thus, efficacy should be confirmed with further studies after adjusting for background factors that can affect ESWT treatment.
Some limitations should be noted. First, the small sample size introduced more obvious heterogeneity between individual studies [23]. Additionally, the included populations were small and the baseline characteristics of included studies were not complete. Thus, subgroup analysis based on age and sex distribution could not be performed. Second, the quality of the included studies was poor, limiting the strength of the conclusion. Third, publication bias for the Harris hip score after treatment might affect the results. Fourth, only two studies reported pain scores, and further research with larger sample sizes is needed to validate the conclusions.
Conclusion
For patients at an early stage, ESWT may be a safe and effective way to relieve pain and improve motor function. Nevertheless, due to the low quality of the included publications, the conclusion should be confirmed with further research using a larger sample size. The long-term follow-up studies are favorable to the use of ESWT in ONFH in future.
Anzeige
Acknowledgements
This work was supported by the key scientific and technological innovation team of Shaanxi province (grant number: 2013KCT-26).
Funding
This work was supported by key scientific and technological innovation team of Shaanxi province (grant number: 2013KCT-26).
Availability of data and materials
All data generated or analyzed during this study are included in this published article [and supplementary information files].
Ethics approval and consent to participate
Not applicable.
Anzeige
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
